Logo image of CRK

COMSTOCK RESOURCES INC (CRK) Stock Fundamental Analysis

USA - NYSE:CRK - US2057683029 - Common Stock

17 USD
-0.73 (-4.12%)
Last: 10/17/2025, 8:04:16 PM
17.3454 USD
+0.35 (+2.03%)
After Hours: 10/17/2025, 8:04:16 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CRK. CRK was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. CRK has a bad profitability rating. Also its financial health evaluation is rather negative. CRK is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CRK was profitable.
CRK had a positive operating cash flow in the past year.
In multiple years CRK reported negative net income over the last 5 years.
In the past 5 years CRK always reported a positive cash flow from operatings.
CRK Yearly Net Income VS EBIT VS OCF VS FCFCRK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

CRK's Return On Assets of -1.25% is on the low side compared to the rest of the industry. CRK is outperformed by 71.56% of its industry peers.
The Return On Equity of CRK (-3.72%) is worse than 69.67% of its industry peers.
The Return On Invested Capital of CRK (2.19%) is worse than 68.72% of its industry peers.
Industry RankSector Rank
ROA -1.25%
ROE -3.72%
ROIC 2.19%
ROA(3y)6.49%
ROA(5y)2.42%
ROE(3y)15.97%
ROE(5y)4.06%
ROIC(3y)N/A
ROIC(5y)N/A
CRK Yearly ROA, ROE, ROICCRK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600

1.3 Margins

The Operating Margin of CRK (9.16%) is worse than 61.61% of its industry peers.
CRK's Gross Margin of 56.59% is fine compared to the rest of the industry. CRK outperforms 65.88% of its industry peers.
CRK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.16%
PM (TTM) N/A
GM 56.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.34%
GM growth 5Y-6.76%
CRK Yearly Profit, Operating, Gross MarginsCRK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRK is destroying value.
The number of shares outstanding for CRK has been increased compared to 1 year ago.
CRK has more shares outstanding than it did 5 years ago.
CRK has a worse debt/assets ratio than last year.
CRK Yearly Shares OutstandingCRK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CRK Yearly Total Debt VS Total AssetsCRK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CRK has an Altman-Z score of 1.06. This is a bad value and indicates that CRK is not financially healthy and even has some risk of bankruptcy.
CRK's Altman-Z score of 1.06 is in line compared to the rest of the industry. CRK outperforms 45.02% of its industry peers.
A Debt/Equity ratio of 1.35 is on the high side and indicates that CRK has dependencies on debt financing.
CRK's Debt to Equity ratio of 1.35 is on the low side compared to the rest of the industry. CRK is outperformed by 72.99% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Altman-Z 1.06
ROIC/WACC0.25
WACC8.77%
CRK Yearly LT Debt VS Equity VS FCFCRK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

CRK has a Current Ratio of 0.36. This is a bad value and indicates that CRK is not financially healthy enough and could expect problems in meeting its short term obligations.
CRK's Current ratio of 0.36 is on the low side compared to the rest of the industry. CRK is outperformed by 91.00% of its industry peers.
CRK has a Quick Ratio of 0.36. This is a bad value and indicates that CRK is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.36, CRK is doing worse than 90.52% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.36
CRK Yearly Current Assets VS Current LiabilitesCRK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

8

3. Growth

3.1 Past

CRK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 433.33%, which is quite impressive.
CRK shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.74%.
Measured over the past years, CRK shows a quite strong growth in Revenue. The Revenue has been growing by 10.28% on average per year.
EPS 1Y (TTM)433.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%165%
Revenue 1Y (TTM)20.74%
Revenue growth 3Y-12.18%
Revenue growth 5Y10.28%
Sales Q2Q%90.52%

3.2 Future

CRK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 105.48% yearly.
The Revenue is expected to grow by 21.08% on average over the next years. This is a very strong growth
EPS Next Y344.79%
EPS Next 2Y167%
EPS Next 3Y99.9%
EPS Next 5Y105.48%
Revenue Next Year49.92%
Revenue Next 2Y31.48%
Revenue Next 3Y21.08%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CRK Yearly Revenue VS EstimatesCRK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CRK Yearly EPS VS EstimatesCRK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 56.67, which means the current valuation is very expensive for CRK.
Based on the Price/Earnings ratio, CRK is valued a bit more expensive than the industry average as 66.82% of the companies are valued more cheaply.
CRK's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.40.
A Price/Forward Earnings ratio of 13.81 indicates a correct valuation of CRK.
CRK's Price/Forward Earnings ratio is in line with the industry average.
CRK is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 56.67
Fwd PE 13.81
CRK Price Earnings VS Forward Price EarningsCRK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CRK.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.98
CRK Per share dataCRK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

CRK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRK's earnings are expected to grow with 99.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y167%
EPS Next 3Y99.9%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.74%, CRK is a good candidate for dividend investing.
The stock price of CRK dropped by -26.60% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 6.28, CRK pays a bit more dividend than its industry peers.
CRK's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 4.74%

5.2 History

CRK has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CRK Yearly Dividends per shareCRK Yearly Dividends per shareYearly Dividends per share 2022 2023 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

DP0%
EPS Next 2Y167%
EPS Next 3Y99.9%
CRK Yearly Income VS Free CF VS DividendCRK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

COMSTOCK RESOURCES INC

NYSE:CRK (10/17/2025, 8:04:16 PM)

After market: 17.3454 +0.35 (+2.03%)

17

-0.73 (-4.12%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners30.91%
Inst Owner Change0.02%
Ins Owners2.22%
Ins Owner Change0.07%
Market Cap4.98B
Analysts55.65
Price Target19.35 (13.82%)
Short Float %24.94%
Short Ratio6.76
Dividend
Industry RankSector Rank
Dividend Yield 4.74%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.14%
Min EPS beat(2)14.38%
Max EPS beat(2)35.9%
EPS beat(4)3
Avg EPS beat(4)149.1%
Min EPS beat(4)-5.01%
Max EPS beat(4)551.11%
EPS beat(8)4
Avg EPS beat(8)74.36%
EPS beat(12)5
Avg EPS beat(12)42.76%
EPS beat(16)7
Avg EPS beat(16)30.9%
Revenue beat(2)2
Avg Revenue beat(2)15.58%
Min Revenue beat(2)10.97%
Max Revenue beat(2)20.2%
Revenue beat(4)2
Avg Revenue beat(4)5.47%
Min Revenue beat(4)-6.71%
Max Revenue beat(4)20.2%
Revenue beat(8)4
Avg Revenue beat(8)1.55%
Revenue beat(12)7
Avg Revenue beat(12)8.01%
Revenue beat(16)11
Avg Revenue beat(16)21.48%
PT rev (1m)-3.07%
PT rev (3m)-13.26%
EPS NQ rev (1m)-13.91%
EPS NQ rev (3m)-51.17%
EPS NY rev (1m)-9%
EPS NY rev (3m)-19.72%
Revenue NQ rev (1m)-1.74%
Revenue NQ rev (3m)-6.64%
Revenue NY rev (1m)-0.72%
Revenue NY rev (3m)3.59%
Valuation
Industry RankSector Rank
PE 56.67
Fwd PE 13.81
P/S 3.01
P/FCF N/A
P/OCF 5.61
P/B 2.22
P/tB 2.61
EV/EBITDA 8.98
EPS(TTM)0.3
EY1.76%
EPS(NY)1.23
Fwd EY7.24%
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)3.03
OCFY17.81%
SpS5.64
BVpS7.66
TBVpS6.51
PEG (NY)0.16
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.25%
ROE -3.72%
ROCE 2.55%
ROIC 2.19%
ROICexc 2.19%
ROICexgc 2.33%
OM 9.16%
PM (TTM) N/A
GM 56.59%
FCFM N/A
ROA(3y)6.49%
ROA(5y)2.42%
ROE(3y)15.97%
ROE(5y)4.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.34%
GM growth 5Y-6.76%
F-Score5
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF N/A
Debt/EBITDA 3.4
Cap/Depr 156.31%
Cap/Sales 69.62%
Interest Coverage 0.74
Cash Conversion 99.92%
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.36
Altman-Z 1.06
F-Score5
WACC8.77%
ROIC/WACC0.25
Cap/Depr(3y)196.86%
Cap/Depr(5y)171.92%
Cap/Sales(3y)69.34%
Cap/Sales(5y)60.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)433.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%165%
EPS Next Y344.79%
EPS Next 2Y167%
EPS Next 3Y99.9%
EPS Next 5Y105.48%
Revenue 1Y (TTM)20.74%
Revenue growth 3Y-12.18%
Revenue growth 5Y10.28%
Sales Q2Q%90.52%
Revenue Next Year49.92%
Revenue Next 2Y31.48%
Revenue Next 3Y21.08%
Revenue Next 5YN/A
EBIT growth 1Y2175.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2207.22%
EBIT Next 3Y219.52%
EBIT Next 5Y141.97%
FCF growth 1Y-160.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-48.71%
OCF growth 3Y-10.28%
OCF growth 5Y6.57%